ClinicalTrials.gg
Status unknownNCT03873753Updated Mar 13, 2019

Relationship Between Oral Hygiene in Newborns and Candida Spp.

An interventional study of Cleaning and No oral cleaning in Candidiasis, Oral, sponsored by Faculty Sao Leopoldo Mandic Campinas. Status unknown at 1 site in Brazil. Open to participants aged Up to 2 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-13.

Sponsored by Faculty Sao Leopoldo Mandic Campinas · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Mar 2019), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled May 2017, registered Feb 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
276
Allocation
Randomized
Ages
Up to 2 Days
Sex
All
01

Study summary

Little is known regarding the effectiveness of neonatal oral hygiene and its relationship to colonization by Candida spp. in edentulous oral cavities. Thus, the objective of this study is to evaluate whether the oral hygiene of edentulous infants favors colonization by Candida spp. Newborns with up to 48 hours of life will randomly allocated to two groups. The mothers will instructed to clean the oral cavity with gauze and mineral water three times a day, in the test group, and not to clean, in the control group.

02

Conditions studied

  • Candidiasis, Oral

Keywords

  • Pediatric dentistry
  • Mouth, Edentulous
03

In context

Candidiasis, Oral

45 studies on the registry are indexed under Candidiasis, Oral; 6 are open to participants now.

This study's planned enrollment of 276 is above the median of 70 across 31 interventional studies indexed under Candidiasis, Oral.

Browse Candidiasis, Oral studies →

Lead sponsor

Faculty Sao Leopoldo Mandic Campinas is the lead sponsor of 13 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 2 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A signed statement of informed consent
  • Newborns up to 48 hours of life
  • Exclusive breastfeeding
  • Edentulous oral cavity

Exclusion criteria

Exclusion Criteria:

  • Any feeding other than breastfeeding
  • Use of pacifier
  • Digit sucking
  • Systemic alterations
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
276 participants (estimated)

Study arms

  • Experimental
    Oral cleaning

    The oral cavity will be clean with gauze and mineral water three times a day.

    Other: Cleaning

  • Active comparator
    No oral cleaning

    The oral cavity will not be cleaned.

    Other: No oral cleaning

Interventions

  • OtherCleaning

    Gauze and mineral water

  • OtherNo oral cleaning

    Absence of cleaning

06

What researchers measure

Primary outcomes

  1. Change from number of Candida spp CFU/mm3

    Non-stimulated saliva will be collected with the aid of a sterile swab (Absorve®) from all infants. The samples were incubated at 37°C and analyzed after 48 hours to quantify the colony forming units (CFU/mm3)

    Time frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)

Secondary outcomes

  1. Mean of patient's birth weight in the test group as assessed by questionnaire

    Time frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)

  2. Number of males in the test group as assessed by questionnaire

    Time frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)

  3. Number of cesarean delivery in the test group as assessed by questionnaire

    Time frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)

  4. Mean of patient's gestational week in the test group as assessed by questionnaire

    Time frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)

  5. Mean of patient's birth length in the test group as assessed by questionnaire

    Time frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)

07

Study locations

1 of 1 sites recruiting
  • Faculty Sao Leopoldo Mandic
    Campinas, São Paulo 13045755, Brazil
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2017 (actual). Primary completion is estimated for Jul 2020, 38 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2019
First posted
Mar 13, 2019
StartActual
May 2, 2017
Primary completionEst.
Jul 31, 2020
CompletionEst.
Dec 30, 2020
Last update
Mar 13, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03873753
Lead sponsor
Faculty Sao Leopoldo Mandic Campinas
Responsible party
Jose Carlos P Imparato (PhD, Senior Lecturer, Clinical Professor, Faculty Sao Leopoldo Mandic Campinas) — Principal investigator
First posted
Mar 13, 2019
Start date
May 2, 2017
Primary completion
Jul 31, 2020 (estimated)
Completion
Dec 30, 2020 (estimated)
Last update
Mar 13, 2019

Study contacts

Sandra Regina E. da Silva, PhD
Contact
secheverria@uol.com.br
+55 11 945179999
Jose Carlos P Imparato, PhD
principal investigator · Faculdade Sao Leopoldo Mandic, Campinas, SP, Brazil

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion